NASDAQ: ENSGEnsign Group Inc Stock
$127.98-0.20 (-0.16%)
Updated Apr 17, 2025
ENSG Price
$127.98
Fair Value Price
$175.20
Market Cap
$7.35B
52 Week Low
$113.27
52 Week High
$158.45
P/E
24.33x
P/B
4x
P/S
1.77x
PEG
2.86x
Dividend Yield
0.14%
Revenue
$4.26B
Earnings
$297.97M
Gross Margin
15.7%
Operating Margin
9.25%
Profit Margin
7%
Debt to Equity
1.54
Operating Cash Flow
$347M
Beta
0.78
Next Earnings
Apr 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ENSG Overview
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ENSG's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
ENSG
Ranked#26 of 42
Ranked#26 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.82 | A | |
| $12.51 | A | |
| $174.80 | A |
Be the first to know about important ENSG news, forecast changes, insider trades & much more!
ENSG News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ENSG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ENSG ($127.98) is undervalued by 26.95% relative to our estimate of its Fair Value price of $175.20 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ENSG ($127.98) is significantly undervalued by 26.95% relative to our estimate of its Fair Value price of $175.20 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ENSG ($127.98) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more ENSG due diligence checks available for Premium users.
Valuation
ENSG fair value
Fair Value of ENSG stock based on Discounted Cash Flow (DCF)
Price
$127.98
Fair Value
$175.20
Undervalued by
26.95%
ENSG ($127.98) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ENSG ($127.98) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ENSG ($127.98) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ENSG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
24.33x
Industry
14.77x
Market
27.98x
ENSG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ENSG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ENSG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4x
Industry
4.22x
ENSG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ENSG price to earnings growth (PEG)
For valuing profitable companies with growth potential
ENSG is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
ENSG's financial health
Profit margin
Revenue
$1.1B
Net Income
$79.7M
Profit Margin
7%
ENSG's Earnings (EBIT) of $393.90M... subscribe to Premium to read more.
Interest Coverage Financials
ENSG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.7B
Liabilities
$2.8B
Debt to equity
1.54
ENSG's short-term assets ($1.16B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENSG's long-term liabilities ($2.09B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENSG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ENSG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$100.5M
Investing
-$166.6M
Financing
-$1.3M
ENSG's operating cash flow ($347.19M)... subscribe to Premium to read more.
Debt Coverage Financials
ENSG vs Medical Care Facility Stocks
Ensign Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.